Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00250562
Status:
COMPLETED
Last Update Posted:
2017-08-01
First Post:
2005-11-06
Brief Title:
A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Multicenter Double-blind Randomized Active Controlled Parallel Group Trial Comparing the Combinations of Valsartan 80 mg Plus Hydrochlorothiazide 125 mg to Valsartan 80 mg in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Valsartan 80mg
Status:
COMPLETED
Status Verified Date:
2016-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Valsartan an orally active angiotensin II receptor blocker is registered in most countries worldwide for the treatment of hypertension In China the usual recommended starting and maintenance dose is 80 mg od The combination of HCTZ 125 mg with valsartan 80 mg has been shown to have additive effects in lowering blood pressure compared to valsartan 80 mg in patients not adequately controlled by valsartan 80 mg monotherapy5 or in non-selected patients6 This fixed combination is registered in most countries worldwide
The potential benefits of these combinations should be evaluated in patients not adequately controlled by valsartan 80 mg monotherapy This study will compare the efficacy safety and tolerability of adding HCTZ 125 mg to valsartan 80 mg in those hypertensive patients
This study is not recruiting in the US
The potential benefits of these combinations should be evaluated in patients not adequately controlled by valsartan 80 mg monotherapy This study will compare the efficacy safety and tolerability of adding HCTZ 125 mg to valsartan 80 mg in those hypertensive patients
This study is not recruiting in the US
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None